Next Article in Journal
ATM Immunohistochemistry as a Tool to Identify and Classify Somatic ATM Variants in Prostate Cancer
Previous Article in Journal
Understanding of Microbial Causes, Clinicopathological Evaluation, Molecular Analysis, and Associated Risk Factors of Ear Infections in Dogs
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JMP
Volume 7
Issue 2
10.3390/jmp7020021
jmp-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to J. Mol. Pathol. 2025, 6(4), 31.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Vernygorodskyi et al. Cancer-Associated Fibroblasts and Epithelial–Mesenchymal Transition as Critical Contributors to Renal Cell Carcinoma Progression. J. Mol. Pathol. 2025, 6, 31

by
Sergii Vernygorodskyi
1,*,
Anton B. Tonchev
1,2,
Nikolai T. Evtimov
1,3 and
Kameliya Zhechkova Bratoeva
1,4
1
Vascular Biology Research Group (RenEVA), Research Institute, Medical University, 9002 Varna, Bulgaria
2
Department of Anatomy and Cell Biology, Medical University, 9002 Varna, Bulgaria
3
Department of Urology, University St Anna Hospital, 9002 Varna, Bulgaria
4
Department of Physiology and Pathophysiology, Medical University, 9002 Varna, Bulgaria
*
Author to whom correspondence should be addressed.
J. Mol. Pathol. 2026, 7(2), 21; https://doi.org/10.3390/jmp7020021
Submission received: 20 May 2026 / Accepted: 22 May 2026 / Published: 30 May 2026
Versions Notes
Following publication of the review article [1], one of the referenced manuscripts was found to have been retracted. To maintain the accuracy of the manuscript, the authors have decided to replace the original reference 42 with a new reference at the same position in the reference list.
Original reference number 42: Wang, P.; Zhang, L.D.; Sun, M.C.; Gu, W.D.; Geng, H.Z. Over-expression of mir-124 inhibits MMP-9 expression and decreases invasion of renal cell carcinoma cells. Eur. Rev. Med. Pharmacol. Sci. 2018, 22, 6308–6314.
New reference number 42: Chen, J.-F.; Ye, S.-Z.; Wang, K.-J.; Meng, X.-y.; Yang, B.-b.; Wu, K.R.; Ma, Q. Long non-coding RNA OSTM1-AS1 promotes renal cell carcinoma progression by sponging miR-491-5p and upregulating MMP-9. Sci. Rep. 2025, 15, 359. https://doi.org/10.1038/s41598-024-83154-4.
The overall numbering and order of the references remain unchanged.
The following text from Section 3, paragraph 10 has been updated after replacing reference 42 “Notably, suppression of MMP-9 via microRNA mir-124 reduces RCC invasiveness in vitro [42].”
Updated text: “Molecular analysis indicates that the long non-coding RNA OSTM1-AS1 drives RCC progression by suppressing miR-491-5p and upregulating MMP-9, while its silencing reverses these effects and reduces invasiveness [42].”
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Vernygorodskyi, S.; Tonchev, A.B.; Evtimov, N.T.; Bratoeva, K.Z. Cancer-Associated Fibroblasts and Epithelial–Mesenchymal Transition as Critical Contributors to Renal Cell Carcinoma Progression. J. Mol. Pathol. 2025, 6, 31. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Vernygorodskyi, S.; Tonchev, A.B.; Evtimov, N.T.; Bratoeva, K.Z. Correction: Vernygorodskyi et al. Cancer-Associated Fibroblasts and Epithelial–Mesenchymal Transition as Critical Contributors to Renal Cell Carcinoma Progression. J. Mol. Pathol. 2025, 6, 31. J. Mol. Pathol. 2026, 7, 21. https://doi.org/10.3390/jmp7020021

AMA Style

Vernygorodskyi S, Tonchev AB, Evtimov NT, Bratoeva KZ. Correction: Vernygorodskyi et al. Cancer-Associated Fibroblasts and Epithelial–Mesenchymal Transition as Critical Contributors to Renal Cell Carcinoma Progression. J. Mol. Pathol. 2025, 6, 31. Journal of Molecular Pathology. 2026; 7(2):21. https://doi.org/10.3390/jmp7020021

Chicago/Turabian Style

Vernygorodskyi, Sergii, Anton B. Tonchev, Nikolai T. Evtimov, and Kameliya Zhechkova Bratoeva. 2026. "Correction: Vernygorodskyi et al. Cancer-Associated Fibroblasts and Epithelial–Mesenchymal Transition as Critical Contributors to Renal Cell Carcinoma Progression. J. Mol. Pathol. 2025, 6, 31" Journal of Molecular Pathology 7, no. 2: 21. https://doi.org/10.3390/jmp7020021

APA Style

Vernygorodskyi, S., Tonchev, A. B., Evtimov, N. T., & Bratoeva, K. Z. (2026). Correction: Vernygorodskyi et al. Cancer-Associated Fibroblasts and Epithelial–Mesenchymal Transition as Critical Contributors to Renal Cell Carcinoma Progression. J. Mol. Pathol. 2025, 6, 31. Journal of Molecular Pathology, 7(2), 21. https://doi.org/10.3390/jmp7020021

Article Metrics

Back to TopTop